SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-20-329894
Filing Date
2020-12-30
Accepted
2020-12-30 16:48:58
Documents
1
Period of Report
2020-12-23
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d38589d8ka.htm 8-K/A 39321
  Complete submission text file 0001193125-20-329894.txt   40606
Mailing Address 4500 GREAT AMERICAN PARKWAY SUITE 100 #29 SANTA CLARA CA 95054
Business Address 4500 GREAT AMERICAN PARKWAY SUITE 100 #29 SANTA CLARA CA 95054 650-800-6676
Vincera Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-39244 | Film No.: 201426392
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences